{"id":2964,"date":"2016-09-26T22:54:13","date_gmt":"2016-09-26T22:54:13","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=17634"},"modified":"2016-09-26T22:54:13","modified_gmt":"2016-09-26T22:54:13","slug":"dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/","title":{"rendered":"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">This week: <\/span><\/p>\n<ul>\n<li>More Clinical Evidence for Medicinal Cannabis \u2013 Australia.<\/li>\n<li>CDC Says Senior Citizen Falls Are on the Rise \u2013 a leading cause of injury and death on older Americans.<\/li>\n<li>Scientific American Says the FDA Manipulates the Media.<\/li>\n<li>Forbes Says Medical Marijuana Seems to Reduce Deaths from Pharmaceuticals.<\/li>\n<\/ul>\n<p>This week a new report from University of Sydney Australia and MCG Pharma indicates more clinical evidence for medicinal marijuana. \u00a0In spite of recent setbacks in the US by our DEA in not rescheduling cannabis, increasing global evidence keeps rolling in regarding the numerous medicinal applications. \u00a0This new 23-page report, a white paper published by University of Sydney Australia in concert with MGC Pharma shows significant medicinal benefit to cannabis. \u00a0With a focus on Epilepsy, Cancer and Multiple Sclerosis, the report is complete with clinical evidence and results from worldwide studies showing cannabis benefits.<\/p>\n<p><span style=\"font-weight: 400;\">To <\/span><a href=\"http:\/\/www.abc.net.au\/news\/2016-06-30\/medicinal-cannabis-trialled-as-melanoma-treatment\/7556084\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">quote the report<\/span><\/a><span style=\"font-weight: 400;\">:<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cIn recent years, medicinal cannabis has gone from being a niche and\u00a0<\/span><span style=\"font-weight: 400;\">obscure area of medical scientific research into \u2018one of the fastest\u00a0<\/span><span style=\"font-weight: 400;\">moving frontiers in pharmacology.\u2019 The potential value of cannabis\u00a0<\/span><span style=\"font-weight: 400;\">as medicine has been demonstrated in relation to a number of\u00a0<\/span><span style=\"font-weight: 400;\">serious conditions and symptoms including cancer, epilepsy, multiple\u00a0<\/span><span style=\"font-weight: 400;\">sclerosis, chronic pain, muscle spasticity and nausea.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In its conclusion, the <\/span><a href=\"http:\/\/www.abc.net.au\/news\/2016-06-30\/medicinal-cannabis-trialled-as-melanoma-treatment\/7556084\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">report cites<\/span><\/a><span style=\"font-weight: 400;\">: \u00a0\u00a0<\/span><\/p>\n<p>\u201cThe field of medicinal cannabis has been constrained and, in\u00a0<span style=\"font-weight: 400;\">many places, prohibited or actively discouraged through onerous\u00a0<\/span><span style=\"font-weight: 400;\">regulatory, legal and social barriers. In spite of all of this, there\u00a0<\/span><span style=\"font-weight: 400;\">is strong evidence demonstrating the effectiveness of medicinal\u00a0<\/span><span style=\"font-weight: 400;\">cannabis in treating the symptoms of pain, nausea, vomiting and\u00a0<\/span><span style=\"font-weight: 400;\">appetite in cancer patients. Medicinal cannabis has also been\u00a0<\/span><span style=\"font-weight: 400;\">demonstrated to be a viable treatment option for the management\u00a0<\/span><span style=\"font-weight: 400;\">of muscle spasticity and pain in people living with MS.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In Australia, the University of Canberra is <\/span><span style=\"font-weight: 400;\">now studying<\/span><span style=\"font-weight: 400;\"> Melanoma Cancer with Cannabis as a medicine. \u00a0Australia, with its abundant sunshine, is considered to have the highest rate for melanoma cancer in the world with an estimated 13,000 new cases to be diagnosed in 2016. \u00a0Melanoma represents the third most abundant form of cancer in Australia \u2013 New Zealand where 1800 people die annually from melanoma. \u00a0<\/span><\/p>\n<p style=\"text-align: center;\"><span style=\"font-weight: 400;\">_________________________________________<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This week the Centers for Disease Control (CDC) mentioned that every second of every day in the United States an older adult falls \u2013 thus making the case for these fall injuries to be the number one cause of injury and death in older Americans. \u00a0<\/span><\/p>\n<p>In 2014, older Americans experienced 29 million falls causing seven million injuries requiring medical attention, to the tune of an estimated $31 billion in Medicare expenditures, according to the CDC. \u00a0Each year fall injuries are responsible for 27,000 deaths in this patient population. With over 10,000 Americans turning 65 years of age every day \u2013 the number of fall-related injuries is expected to spike, as is the overall expenditure to treat these patients, unless preventative measures are taken.<\/p>\n<p><span style=\"font-weight: 400;\">\u201cFalls threaten older Americans\u2019 independence and safety and generate enormous economic and personal costs that affect everyone,\u201d <\/span><a href=\"https:\/\/www.cdc.gov\/media\/releases\/2016\/p0922-older-adult-falls.html\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">said<\/span><\/a><span style=\"font-weight: 400;\"> Grant Baldwin, Ph.D., M.P.H., director of CDC\u2019s Division of Unintentional Injury Prevention. \u201cTogether, everyone can reduce the risk of falling and prevent fall injuries.\u201d<\/span><\/p>\n<p>Reduced muscle strength, increased inactivity, more severe chronic health conditions, and increased use of prescription medications are risk factors for falls among older Americans. Fall injury rates are almost seven times higher for older adults with poor health than for those with excellent health.<\/p>\n<p>Certainly we believe that hemp-based CBD assists with bone health as two US pharma companies have partnered with Israeli research organizations to explore bone healing and osteoporosis \/ bone health conditions (Kalytera Pharmaceuticals and OWC Pharma OTC: OWCP). \u00a0Further CBD can potentially provide cognitive health benefits that may improve focus and stability. \u00a0To repeat from above \u2013 fall injury rates are 7 times greater for older adults with poor health than for those with excellent health.<\/p>\n<p style=\"text-align: center;\"><span style=\"font-weight: 400;\">_________________________________________<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Scientific American this week <\/span><a href=\"http:\/\/www.scientificamerican.com\/article\/how-the-fda-manipulates-the-media\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">released<\/span><\/a><span style=\"font-weight: 400;\"> a bombshell criticism of the US Food and Drug Administration (FDA) in its report titled: <\/span><em><span style=\"font-weight: 400;\">How the FDA Manipulates the Media<\/span><\/em><span style=\"font-weight: 400;\">. \u00a0According to Scientific American, the FDA has been arm-twisting the strong-arming journalists into relinquishing their independent reporting standards \u2013 and that other institutions are following suit. \u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">New York Times former public editor Margaret Sullivan mentioned: \u201cI think (news) embargoes that attempt to control sourcing are dangerous because they limit the role of the reporter whose job it is to do a full look at a subject\u201d. \u00a0Further that \u201cit\u2019s really inappropriate to be telling a journalist whom he or she can\u2019t talk to.\u201d \u00a0<\/span><\/p>\n<p>This kind of deal offered by the FDA \u2013 known as a close-hold embargo \u2013 is an increasingly important tool used by scientific and government agencies to control the behavior of the science press. \u00a0Documents obtained by Scientific American via Freedom of Information Act (FOIA) requests paint a newly disturbing picture of the tactics that are used to control the science press and news media. \u00a0A surprisingly large percentage of science and health stories are the product of news embargoes.<\/p>\n<p><span style=\"font-weight: 400;\">Instances of certain favored reporters and news services receiving exceptional offers to \u201chave their stories shaped\u201d are increasingly common. \u00a0Certain reporters were given \u201cinside track\u201d information regarding e-cigarettes in recent times, including Fox News. \u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">We wonder if we Americans are getting the full story \u2013 or only portions that our federal officials want us to see\u2026 \u00a0We do encourage more open discussion regarding artificial sugar, GMO, and the medicinal aspects of cannabis.<\/span><\/p>\n<p style=\"text-align: center;\">_________________________________________<\/p>\n<p><span style=\"font-weight: 400;\">Medical Marijuana Seems to Reduce Deaths from Pharmaceuticals <\/span><a href=\"http:\/\/www.forbes.com\/sites\/jacobsullum\/2016\/09\/22\/medical-marijuana-seems-to-reduce-deaths-from-pharmaceuticals\/#4fe97633396e\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">according to Forbes contributor Jacob Sullum<\/span><\/a><span style=\"font-weight: 400;\">. \u00a0In the article, Insys Therapeutics is mentioned, an Arizona based pharmaceutical company that recently became the biggest financial supporter against medical marijuana legalization for recreational purposes in the State. \u00a0Insys gave $500,000 to the main group opposing Arizona\u2019s legalization efforts because the ballot measure \u201cfails to protect the safety of Arizona\u2019s citizens and particularly its children\u201d. \u00a0One need not be too cynical to surmise that Insys also worries about the impact that legalization may have on profits and the bottom line \u2013 since marijuana could compete with its synthetic products. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Insys manufacturers an oral spray that delivers the opioid painkiller fentanyl and plans to market another one that contains dronabinol, a synthetic version of THC. A recent study shows that Insys has reason to worry\u2026 \u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In an article published recently by the American Journal of Public health, Columbia University epidemiologist June Kim and her colleagues report that \u201cfatally injured drivers are less likely to test positive for opioids in states that allow medicinal use of marijuana. \u00a0That finding, together with the results of earlier studies, indicates that making marijuana legally available to patients saves lives by reducing their consumption of more dangerous medications.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Statistics reported herein are equally astounding:<\/span><\/p>\n<div id=\"attachment_17640\" style=\"width: 650px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-17640\" class=\"wp-image-17640 size-large\" src=\"https:\/\/www.medicalmarijuanainc.com\/wp-content\/uploads\/2016\/09\/prescription-changes-table-Health-Affairs-1200x678-1024x579.jpg\" alt=\"prescription-changes-table-health-affairs-1200x678\" width=\"640\" height=\"362\" \/><p id=\"caption-attachment-17640\" class=\"wp-caption-text\">Prescription changes associated with medical marijuana laws (Image: Health Affairs)<\/p><\/div>\n<p><span style=\"font-weight: 400;\">Other studies indicate that replacing prescription drugs with marijuana reduces opioid-related deaths. A\u00a0<\/span><a href=\"http:\/\/archinte.jamanetwork.com\/article.aspx?articleid=1898878\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">2014 study<\/span><\/a><span style=\"font-weight: 400;\">\u00a0reported in\u00a0JAMA Internal Medicine, based on death certificate data from 1999 through 2010, found that \u201cstates with medical cannabis laws had a 24.8% lower mean annual opioid overdose mortality rate\u2026compared with states without medical cannabis laws.\u201d Furthermore, internist Marcus Bachhuber and his co-authors reported, \u201csuch laws were associated with a lower rate of overdose mortality that generally strengthened over time,\u201d which makes sense if more patients are switching to marijuana from opioids (or choosing marijuana rather than opioids) each year.<\/span><\/p>\n<p>The reduced rate of opioid-related fatalities translated into about 1,700 fewer deaths in 2010 alone. The researchers suggest several possible explanations for this effect. \u201cPatients with chronic non-cancer pain who would have otherwise initiated opioid analgesics may choose medical cannabis instead,\u201d Bachhuber et al. write. \u201cIn addition, patients already receiving opioid analgesics who start medical cannabis treatment may experience improved analgesia and\u00a0decrease their opioid dose, thus potentially decreasing their dose-dependent risk of overdose. Finally, if medical cannabis laws lead to decreases in polypharmacy\u2014particularly with benzodiazepines\u2014in people taking opioid analgesics, overdose risk would be decreased.\u201d<\/p>\n<p>Amazing statistics and certainly we encourage debate among our politicians to re-examine the marijuana legalities with full de-scheduling. \u00a0I look forward to additional items of newsworthiness supporting our cause in next week\u2019s edition.<\/p>\n<p><span style=\"font-weight: 400;\">To good health,<\/span><\/p>\n<p>Stu<\/p>\n<p><span style=\"font-weight: 400;\">Stuart W Titus, PhD<\/span><\/p>\n<p><span style=\"font-weight: 400;\">President &amp; CEO<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Medical Marijuana Inc. (OTC: MJNA)<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This week: More Clinical Evidence for Medicinal Cannabis \u2013 Australia. CDC Says Senior Citizen Falls Are on the Rise \u2013 a leading cause of injury and death on older Americans. Scientific American Says the FDA Manipulates the Media. Forbes Says Medical Marijuana Seems to Reduce Deaths from Pharmaceuticals. This week a new report from University [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2741,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3,195,185,9],"tags":[],"class_list":["post-2964","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-dr-titus-insights","category-industry-updates","category-scientific-research"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media - Medical Marijuana, Inc.<\/title>\n<meta name=\"description\" content=\"This week, our CEO Dr. Titus discusses recent medical marijuana news covering Australia, pharmaceutical companies, and the role of the FDA in the media.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media - Medical Marijuana, Inc.\" \/>\n<meta property=\"og:description\" content=\"This week, our CEO Dr. Titus discusses recent medical marijuana news covering Australia, pharmaceutical companies, and the role of the FDA in the media.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Marijuana, Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MJNAInc\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-26T22:54:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/07\/UT-Radio-MJNA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminTorusBrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:site\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminTorusBrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/\"},\"author\":{\"name\":\"adminTorusBrand\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\"},\"headline\":\"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media\",\"datePublished\":\"2016-09-26T22:54:13+00:00\",\"dateModified\":\"2016-09-26T22:54:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/\"},\"wordCount\":1363,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"articleSection\":[\"Company News\",\"Dr. Titus Insights\",\"Industry Updates\",\"Scientific Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/\",\"name\":\"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media - Medical Marijuana, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\"},\"datePublished\":\"2016-09-26T22:54:13+00:00\",\"dateModified\":\"2016-09-26T22:54:13+00:00\",\"description\":\"This week, our CEO Dr. Titus discusses recent medical marijuana news covering Australia, pharmaceutical companies, and the role of the FDA in the media.\",\"breadcrumb\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicalmarijuanainc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"name\":\"Medical Marijuana, Inc.\",\"description\":\"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!\",\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\",\"name\":\"Medical Marijuana, Inc.\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"contentUrl\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Marijuana, Inc.\"},\"image\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MJNAInc\",\"https:\/\/twitter.com\/mjna_inc\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\",\"name\":\"adminTorusBrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"caption\":\"adminTorusBrand\"},\"sameAs\":[\"https:\/\/medicalmarijuanainc.com\"],\"url\":\"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media - Medical Marijuana, Inc.","description":"This week, our CEO Dr. Titus discusses recent medical marijuana news covering Australia, pharmaceutical companies, and the role of the FDA in the media.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media - Medical Marijuana, Inc.","og_description":"This week, our CEO Dr. Titus discusses recent medical marijuana news covering Australia, pharmaceutical companies, and the role of the FDA in the media.","og_url":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/","og_site_name":"Medical Marijuana, Inc.","article_publisher":"https:\/\/www.facebook.com\/MJNAInc","article_published_time":"2016-09-26T22:54:13+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/07\/UT-Radio-MJNA.jpg","type":"image\/jpeg"}],"author":"adminTorusBrand","twitter_card":"summary_large_image","twitter_creator":"@mjna_inc","twitter_site":"@mjna_inc","twitter_misc":{"Written by":"adminTorusBrand","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#article","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/"},"author":{"name":"adminTorusBrand","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c"},"headline":"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media","datePublished":"2016-09-26T22:54:13+00:00","dateModified":"2016-09-26T22:54:13+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/"},"wordCount":1363,"commentCount":0,"publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"articleSection":["Company News","Dr. Titus Insights","Industry Updates","Scientific Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/","url":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/","name":"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media - Medical Marijuana, Inc.","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/#website"},"datePublished":"2016-09-26T22:54:13+00:00","dateModified":"2016-09-26T22:54:13+00:00","description":"This week, our CEO Dr. Titus discusses recent medical marijuana news covering Australia, pharmaceutical companies, and the role of the FDA in the media.","breadcrumb":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalmarijuanainc.com\/2016\/09\/26\/dr-titus-insights-medical-marijuana-australia-pharmaceuticals-media\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicalmarijuanainc.com\/"},{"@type":"ListItem","position":2,"name":"Dr. Titus Insights: Medical Marijuana and Australia, Pharmaceuticals, and the Media"}]},{"@type":"WebSite","@id":"https:\/\/medicalmarijuanainc.com\/#website","url":"https:\/\/medicalmarijuanainc.com\/","name":"Medical Marijuana, Inc.","description":"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!","publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalmarijuanainc.com\/#organization","name":"Medical Marijuana, Inc.","url":"https:\/\/medicalmarijuanainc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/","url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","contentUrl":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","width":512,"height":512,"caption":"Medical Marijuana, Inc."},"image":{"@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MJNAInc","https:\/\/twitter.com\/mjna_inc"]},{"@type":"Person","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c","name":"adminTorusBrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","caption":"adminTorusBrand"},"sameAs":["https:\/\/medicalmarijuanainc.com"],"url":"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/"}]}},"_links":{"self":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/comments?post=2964"}],"version-history":[{"count":0,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2964\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media\/2741"}],"wp:attachment":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media?parent=2964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/categories?post=2964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/tags?post=2964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}